AGTR1 and Parkinson disease: Blocking AT1 receptors is suggested to be advantageous in neurodegenerative conditions such as Alzheimer’s and Parkinson’s diseases, traumatic brain injury, and radiation-induced brain damage, as well as stress and mood disorders [58,59,64].